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Background: The Logistic EuroSCORE (LES) and the Society of Thoracic Surgery score (STS) are validated risk scores predicting 30-day outcomes 
in patients undergoing surgical aortic valve replacement with or without coronary artery bypass grafting. The performance characteristics of these 
scores applied to transcatheter aortic valve replacement (TAVR) are controversial. 
methods: We compared predicted and observed 30 day/in-hospital mortality of patients undergoing TAVR in the PARTNER inoperable and high risk 
randomized trials and continued access registries (n=2552). The performance of the LES and STS scores was evaluated using standard assessments 
of discrimination and calibration. 
results: Among patients undergoing TAVR, the observed mortality was 6.5% while the predicted mortality was significantly higher by both STS 
(11.4%±3.9%) and LES (26.6±16.2%). STS and LES were weakly correlated (r2=0.12). The STS demonstrated greater discriminatory power than 
the LES score (AUC 0.60 vs 0.53), but the overall discriminatory power for both scores was not robust (Figure). Calibration of the scores to clinical 
outcomes (Hosmer-Lemeshow test), was good for STS (p=0.3) but poor for LES (p<0.001). 
conclusions: Existing surgical risk scores are poor discriminators of 30 day/in-hospital outcomes of TAVR, but exhibit some degree of calibration 
to these outcomes (specifically STS). TAVR-specific risk models need to be developed to optimize patient selection. 
